JNJ Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

268.600

Open

268.600

VWAP

265.04

Vol

6.71M

Mkt Cap

643.30B

Low

263.130

Amount

1.78B

EV/EBITDA(TTM)

19.00

Total Shares

2.41B

657.20B

EV/OCF(TTM)

28.74

P/S(TTM)

6.55

Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Events Timeline

(ET)

2026-07-08

08:00:00

Johnson & Johnson Receives FDA Approval for Dual Energy THERMOCOOL SMARTTOUCH SF Platform

2026-06-30 (ET)

2026-06-30

14:00:00

AWS Invests $1 Billion to Establish Forward Deployed Engineering Organization

2026-06-30

13:30:00

Anthropic Launches Claude Science for Scientific Research

2026-06-26 (ET)

2026-06-26

13:00:00

Johnson & Johnson Presents New IMAAVY Data at European Neurology Congress

2026-06-26

09:00:00

Guggenheim Raises Johnson & Johnson Price Target to $270

2026-06-25 (ET)

2026-06-25

05:30:00

Johnson & Johnson Launches Dual Energy Thermocool Smarttouch SF Platform in Europe

News

9.5

07-06Newsfilter

PinnedStrong Earnings Expectations Drive JNJ Stock Up

8.0

07-07Fool

Dividend Investment Opportunities in Pfizer and Bristol Myers Squibb

7.5

07-07Fool

U.S. Healthcare Spending Reaches $5.7 Trillion Amid Growth Trends

8.0

07-07Fool

Dividend Kings: Steady Growth Investment Choices

8.5

07-07NASDAQ.COM

Eli Lilly and Intuitive Surgical's Growth Potential

4.5

07-07CNBC

Market Update: Tech Stocks Retreat, Healthcare Sector Gains

20 Analyst Rating

Wall Street analysts forecast JNJ stock price to rise

13 Buy

7 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

190.00

Averages

218.50

High

240.00

Current: 0.000

Low

190.00

Averages

218.50

High

240.00

HSBC

Buy

maintain

$280 -> $290

AI Analysis

2026-07-06

New

Reason

HSBC

Price Target

$280 -> $290

AI Analysis

2026-07-06

New

maintain

Buy

Reason

HSBC raised the firm's price target on Johnson & Johnson to $290 from $280 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space offering "attractive risk weighted returns," Tools "might be the best way to play a cyclical rally," and that MedTech is "cheap."

Leerink

Market Perform

Outperform

upgrade

$252 -> $265

2026-05-13

Reason

Leerink

Price Target

$252 -> $265

2026-05-13

upgrade

Market Perform

Outperform

Reason

Leerink upgraded Johnson & Johnson to Outperform from Market Perform with a price target of $265, up from $252. The firm says the company's "strong new drug momentum" will drive accelerating revenue growth and share outperformance. Leerink upped its estimates for Icotyde and Inlexzo and believes J&J at its December 8 analyst day will "provide more justification for its aspiration" to deliver double-digit revenue growth late in the decade.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for JNJ

Unlock Now

Valuation Metrics

The current forward P/E ratio for Johnson & Johnson (JNJ.N) is 22.73, compared to its 5-year average forward P/E of 16.28. For a more detailed relative valuation and DCF analysis to assess Johnson & Johnson's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

16.28

Current PE

22.73

Overvalued PE

17.82

Undervalued PE

14.73

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

13.13

Current EV/EBITDA

16.66

Overvalued EV/EBITDA

14.23

Undervalued EV/EBITDA

12.02

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

4.57

Current PS

5.80

Overvalued PS

4.99

Undervalued PS

4.15

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

us stovks

Intellectia · 4073 candidates

Region: USList Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.66T

AAPL

Apple Inc

4.17T

GOOG

Alphabet Inc

4.06T

MSFT

Microsoft Corp

2.77T

AMZN

Amazon.com Inc

2.50T

TSM

Taiwan Semiconductor Manufacturing Co Ltd

2.24T

S&P 500

Intellectia · 473 candidates

Is Index Component: GSPC

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

5.10T

GOOG

Alphabet Inc

4.45T

AAPL

Apple Inc

4.38T

MSFT

Microsoft Corp

2.82T

AMZN

Amazon.com Inc

2.63T

AVGO

Broadcom Inc

1.96T

what are those stocks?>

Intellectia · 4081 candidates

Region: USPrice: >= $0.00

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.95T

GOOG

Alphabet Inc

4.39T

AAPL

Apple Inc

4.35T

MSFT

Microsoft Corp

2.81T

AMZN

Amazon.com Inc

2.55T

TSM

Taiwan Semiconductor Manufacturing Co Ltd

2.24T

sp500 daily bias

Intellectia · 2411 candidates

Moving Average Relationship: PriceAboveMA5, PriceAboveMA20Macd: bullish

Ticker

Name

Market Cap$

SPCX

Space Exploration Technologies Corp

2.52T

BRK.A

Berkshire Hathaway Inc

1.07T

BRK.B

Berkshire Hathaway Inc

1.07T

WMT

Walmart Inc

961.50B

JPM

JPMorgan Chase & Co

855.84B

ASML

ASML Holding NV

729.46B

give me us30 biggest movers by market cap

Intellectia · 29 candidates

Region: USIs Index Component: DJI

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

5.14T

AAPL

Apple Inc

4.35T

MSFT

Microsoft Corp

2.97T

AMZN

Amazon.com Inc

2.65T

WMT

Walmart Inc

961.50B

JPM

JPMorgan Chase & Co

855.84B

Us30 companies and their performance

Intellectia · 29 candidates

Region: USIs Index Component: DJI

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.97T

AAPL

Apple Inc

4.28T

MSFT

Microsoft Corp

2.90T

AMZN

Amazon.com Inc

2.57T

WMT

Walmart Inc

963.25B

JPM

JPMorgan Chase & Co

859.37B

Elite pharma

Intellectia · 9 candidates

Sector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchIndustry: Biotechnology & Medical Research, PharmaceuticalsPrice: >= $-100.00Volume: >= -100Themes: Medical Instruments & Supplies, Genomics, Cancer Research, BiotechRsi Category: moderateMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Ema 20: >= -100Ema 60: >= -100Weekly Average Dollar Volume: >= -100

Ticker

Name

Market Cap$

JNJ

Johnson & Johnson

570.51B

ABBV

AbbVie Inc

398.27B

MRK

Merck & Co Inc

295.39B

AMGN

Amgen Inc

185.96B

VRTX

Vertex Pharmaceuticals Inc

113.14B

BIIB

Biogen Inc

29.39B

purchase stock

Intellectia · 4087 candidates

Region: USList Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

5.29T

AAPL

Apple Inc

4.57T

GOOG

Alphabet Inc

4.47T

MSFT

Microsoft Corp

3.18T

AMZN

Amazon.com Inc

2.73T

TSM

Taiwan Semiconductor Manufacturing Co Ltd

2.31T

هل يمكنك البحث عن أسهم قيادية ذات عقود كول بمتوسط تكلفة أقل من 2 دولار، بغض النظر عن سعر السهم نفسه؟

Intellectia · 485 candidates

Is Optionable: TrueIs Index Component: GSPC, NDX

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

5.11T

AAPL

Apple Inc

4.58T

GOOG

Alphabet Inc

4.56T

MSFT

Microsoft Corp

3.34T

AMZN

Amazon.com Inc

2.91T

AVGO

Broadcom Inc

2.12T

stock

Intellectia · 4065 candidates

Region: US

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

5.31T

GOOG

Alphabet Inc

4.65T

AAPL

Apple Inc

4.48T

MSFT

Microsoft Corp

3.11T

AMZN

Amazon.com Inc

2.89T

TSM

Taiwan Semiconductor Manufacturing Co Ltd

2.11T

Whales Holding JNJ

Capital Investment Trust Corporation

Pallas Capital Advisors LLC

Epoch Investment Partners, Inc.

Amundi Luxembourg S.A.

Bellevue Asset Management AG

ARS Investment Partners, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Johnson & Johnson (JNJ) stock price today?

The current price of JNJ is 263.4 USD — it has decreased -1.44

What is Johnson & Johnson (JNJ)'s business?

What is the price predicton of JNJ Stock?

Wall Street analysts forecast JNJ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JNJ is218.50 USD with a low forecast of 190.00 USD and a high forecast of 240.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.